Newsletter 06/2014


Centogene CEO position changed: Michael Schlenk hands over to founder Prof Arndt Rolfs

Press release ::
After 3.5 years as Chief Executive Officer for Centogene and the successful completion of a 2-digit million deal with LifeLabs, the largest clinical-diagnostic laboratory in Canada, Michael Schlenk transfers the responsibilities as CEO to Prof. Arndt Rolfs MD.
Schlenk will continue to support the company as an active member of the supervisory board.

Over the last few years Centogene, an always profitable, completely venture capital free and rapidly growing company in the North of Germany, increased turnover and number of employees 4 fold. Today, Centogene is one of the leading molecular genetic diagnostic companies worldwide, specializing in rare diseases.
With the broadest portfolio of over 2,000 genetic tests, whole-exome and whole-genome platform as well as mass-spectometry unit Centogene is a one-stop-shop for many of its customers from over 90 countries.

"With the capital from the Canadian partnership deal, we have the funds to further invest in technological expansion and automation. We will aggressively expand our Next Generation Sequencing leadership with over 150 specific and highly validated panels, the robots processing industry screening projects and the centerpiece of our business model, the CentoMD® Mutation Database," explains Michael Schlenk. "We are very fortunate that we could win the internationally reputated expert in genetics, our founder and visionary leader in genetics, Prof. Rolfs, to drive the technological expansion and raise Centogene to the next level as the new Chief Executive Officer".

"Michael Schlenk will continue to support us with his network and strategic understanding as an active member of the supervisory board. We thank him for his substantial contributions in closing several very important business deals as a basis for further growth of Centogene," said Prof. Arndt Rolfs, new CEO of Centogene AG.

Download press release here.

If you have any questions or comments, please do not hesitate to contact us

Best regards,

Doreen Niemann
Senior Director Strategic Communication
Centogene AG


Centogene AG
Schillingallee 68
18057 Rostock


Responsible: Doreen Niemann
USt-IdNr.: DE813228872